Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

A Decision Analysis of Unrelated Hematopoietic Stem Cell Transplantation for Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia In First Remission Who Lack An HLA-Matched Sibling

Blood (2010) 116 (21): 3527.

https://doi.org/10.1182/blood.V116.21.3527.3527

Published: 2010

Journal Articles

Outcome by Treatment Including An Intensified Consolidation Program with Dose-Escalated Doxorubicin for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL): A Study by the Japan Adult Leukemia Study Group (JALSG ALL97 study).

Itsuro Jinnai, MD, Tohru Sakura, MD, Motohiro Tsuzuki, MD, Yasuhiro Maeda, MD, PhD, Noriko Usui, MD, Masayuki Kato, MD, Hirokazu Okumura, MD, PhD, Yasunori Ueda, MD, Yuji Kishimoto, MD, Fumiharu Yagasaki, MD, Jin Takeuchi, MD, Masako Iwanaga, MD, Yasushi Miyazaki, MD, Shuichi Miyawaki, MD, Kazunori Ohnishi, MD, PhD, Tomoki Naoe, MD, Ph.D., Ryuzo Ohno, MD

Blood (2009) 114 (22): 4334.

https://doi.org/10.1182/blood.V114.22.4334.4334

Published: 2009

Journal Articles

Promising Outcome of Imatinib-Combined Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the Japan Adult Leukemia Study Group (JALSG) Ph+ALL202 Regimen.

Yoshihiro Hatta, Shuichi Mizuta, Shigeki Ohtake, MD, PhD, Isamu Sugiura, MD, PhD, Yasunori Ueda, MD, Heiwa Kanamori, Hideki Akiyama, Makoto Takeuchi, Noriko Usui, Toshiaki Yujiri, Atsushi Fujieda, Toru Kiguchi, MD, Itsuro Jinnai, MD, Tomoki Naoe, MD, PhD, Ryuzo Ohno, MD

Blood (2009) 114 (22): 3090.

https://doi.org/10.1182/blood.V114.22.3090.3090

Published: 2009

Journal Articles

Serum Erythropoietin Dose Not Participate in Anemia That Persists in CML Patients after MMR Achievement by Imatinib Mesylate Therapy

Maho Ishikawa, MD, PhD, Fumiharu Yagasaki, MD, PhD, Daisuke Okamura, MD, Tomoya Maeda, MD, PhD, Naoki Takahashi, MD, PhD, Nobutaka Kawai, MD, PhD, Akira Matsuda, MD, PhD, Itsuro Jinnai, MD, PhD, Masami Bessho, MD, PhD

Blood (2008) 112 (11): 4274.

https://doi.org/10.1182/blood.V112.11.4274.4274

Published: 2008

Journal Articles

Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation during First Complete Remission Following Imatinib-Combined Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Shuichi Mizuta, Masamitsu Yanada, Isamu Sugiura, Fumiharu Yagasaki, Toshiaki Yujiri, Makoto Takeuchi, Yoshihiro Hatta, Yukihiko Kimura, Yasunori Ueda, MD, Heiwa Kanamori, Noriko Usui, Hideki Akiyama, Yasushi Miyazaki, MD, PhD, Shigeki Ohtake, Itsuro Jinnai, MD, Keitaro Matsuo, Tomoki Naoe, MD, Ryuzo Ohno, MD

Blood (2008) 112 (11): 462.

https://doi.org/10.1182/blood.V112.11.462.462

Published: 2008

Journal Articles

Proline-Rich Tyrosine Kinase-2 (PYK2): A New Target for the Treatment of Hematopoietic Neoplasms with TEL-FGFR3 Fusion or FGFR3 Active Mutation.

Daisuke Okamura, Fumiharu Yagasaki, Tomoya Maeda, Maho Ishikawa, Itsuro Jinnai, Masami Bessho

Blood (2007) 110 (11): 3360.

https://doi.org/10.1182/blood.V110.11.3360.3360

Published: 2007

Journal Articles

Factors Associated with Relapse-Free Survival in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Imatinib-Combined Chemotherapy.

Masamitsu Yanada, MD, Jin Takeuchi, MD, Isamu Sugiura, MD, Hideki Akiyama, MD, Noriko Usui, MD, Fumiharu Yagasaki, MD, Kazuhiro Nishii, MD, Yasunori Ueda, MD, Makoto Takeuchi, MD, Shuichi Miyawaki, MD, Atsuo Maruta, MD, Hiroto Narimatsu, MD, Yasushi Miyazaki, MD, Shigeki Ohtake, MD, Itsuro Jinnai, MD, Keitaro Matsuo, MD, Tomoki Naoe, MD, Ryuzo Ohno, MD

Blood (2007) 110 (11): 2813.

https://doi.org/10.1182/blood.V110.11.2813.2813

Published: 2007

Journal Articles

Dasatinib (SPRYCEL®, BMS-354825) Phase-I/II Study of Patients with Chronic Myeloid Leukemia (CML) Resistant or Intolerant to Imatinib: Results of the CA180031 Study in Japan (Phase I Portion).

Hisashi Sakamaki, Shin Fujisawa, Kensei Tobinai, Masafumi Taniwaki, Shuichi Miyawaki, Itsuro Jinnai, Atae Utsunomiya, Mistune Tanimoto, Yasuo Morishima, Masaya Okada, Yasushi Miyazaki, Nobuhiko Uoshima, Taku Seriu, Ryuzo Ohno

Blood (2006) 108 (11): 4809.

https://doi.org/10.1182/blood.V108.11.4809.4809

Published: 2006

Journal Articles

High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia.

Masamitsu Yanada, MD, Jin Takeuchi, MD, Isamu Sugiura, MD, Hideki Akiyama, MD, Noriko Usui, MD, Fumiharu Yagasaki, MD, Nobuhiko Emi, MD, Yasushi Miyazaki, MD, Shigeki Ohtake, MD, Itsuro Jinnai, MD, Keitaro Matsuo, MD, Tomoki Naoe, MD, Ryuzo Ohno, MD

Blood (2005) 106 (11): 1827.

https://doi.org/10.1182/blood.V106.11.1827.1827

Published: 2005

Journal Articles

Recommended Repeated Intrathecal Ara-C/MTX/PDN Injections during Rituximab-Based Therapy for B-Cell Lymphoma.

Daisuke Wakao, MD, PhD, Toshiya Suzuki, MD, PhD, Katsuro Ito, MD, PhD, Katsuhiko Yoshida, MD, PhD, Itsuro Jinnai, MD, PhD, Masami Bessho, MD, PhD

Blood (2005) 106 (11): 4720.

https://doi.org/10.1182/blood.V106.11.4720.4720

Published: 2005

Journal Articles

Expression of ERK1/ERK2 MAP Kinase, Protein Kinase C and Akt Kinase by Lymphoid Malignant Cells.

Ikuo Murohashi, MD, Takashi Takahashi, MD, Noriko Ihara, MS, Daisuke Wakao, MD, Fumiharu Yagasaki, MD, Yhuichi Nakamura, MD, Nobutaka Kawai, MD, Akira Matsuda, MD, Itsuro Jinnai, MD, Masami Bessho, MD

Blood (2005) 106 (11): 4391.

https://doi.org/10.1182/blood.V106.11.4391.4391

Published: 2005

Journal Articles

Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes

Akira Matsuda, Ulrich Germing, Itsuro Jinnai, Motohiro Misumi, Andrea Kuendgen, Sabine Knipp, Manuel Aivado, Masako Iwanaga, Yasushi Miyazaki, Hideki Tsushima, Mari Sakai, Masami Bessho, Masao Tomonaga

Blood (2005) 106 (8): 2633–2640.

https://doi.org/10.1182/blood-2005-01-0040

Published: 2005

Journal Articles

Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL –positive acute lymphoblastic leukemia

Masayuki Towatari, Masamitsu Yanada, Noriko Usui, Jin Takeuchi, Isamu Sugiura, Makoto Takeuchi, Fumiharu Yagasaki, Yasukazu Kawai, Shuichi Miyawaki, Shigeki Ohtake, Itsuro Jinnai, Keitaro Matsuo, Tomoki Naoe, Ryuzo Ohno, for the Japan Adult Leukemia Study Group

Blood (2004) 104 (12): 3507–3512.

https://doi.org/10.1182/blood-2004-04-1389

Published: 2004

Journal Articles

A Novel Fusion, KIAA0379 (Ankyrin Repeat Domain 28) to NUP98 in an Adult MDS/AML with a t(3;5;11)(p25;q35;p15).

Maho Ishikawa, Fumiharu Yagasaki, Daisuke Okamura, Tomoya Maeda, Yuichi Sugahara, Motohiro Misumi, Katsuhiko Yoshida, Yuichi Nakamura, Nobutaka Kawai, Akira Matsuda, Itsuro Jinnai, Masami Bessho

Blood (2004) 104 (11): 4278.

https://doi.org/10.1182/blood.V104.11.4278.4278

Published: 2004

Journal Articles

Prognostic Implication of FLT3 and N- RAS Gene Mutations in Acute Myeloid Leukemia

Hitoshi Kiyoi, Tomoki Naoe, Yasuyuki Nakano, Shohei Yokota, Saburo Minami, Shuichi Miyawaki, Norio Asou, Kazutaka Kuriyama, Itsuro Jinnai, Chihiro Shimazaki, Hideki Akiyama, Kenji Saito, Hakumei Oh, Toshiko Motoji, Eijiro Omoto, Hidehiko Saito, Ryuzo Ohno, Ryuzo Ueda

Blood (1999) 93 (9): 3074–3080.

https://doi.org/10.1182/blood.V93.9.3074

Published: 1999

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

A Decision Analysis of Unrelated Hematopoietic Stem Cell Transplantation for Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia In First Remission Who Lack An HLA-Matched Sibling

Outcome by Treatment Including An Intensified Consolidation Program with Dose-Escalated Doxorubicin for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL): A Study by the Japan Adult Leukemia Study Group (JALSG ALL97 study).

Promising Outcome of Imatinib-Combined Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the Japan Adult Leukemia Study Group (JALSG) Ph+ALL202 Regimen.

Serum Erythropoietin Dose Not Participate in Anemia That Persists in CML Patients after MMR Achievement by Imatinib Mesylate Therapy

Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation during First Complete Remission Following Imatinib-Combined Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Proline-Rich Tyrosine Kinase-2 (PYK2): A New Target for the Treatment of Hematopoietic Neoplasms with TEL-FGFR3 Fusion or FGFR3 Active Mutation.

Factors Associated with Relapse-Free Survival in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Imatinib-Combined Chemotherapy.

Dasatinib (SPRYCEL®, BMS-354825) Phase-I/II Study of Patients with Chronic Myeloid Leukemia (CML) Resistant or Intolerant to Imatinib: Results of the CA180031 Study in Japan (Phase I Portion).

High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia.

Recommended Repeated Intrathecal Ara-C/MTX/PDN Injections during Rituximab-Based Therapy for B-Cell Lymphoma.

Expression of ERK1/ERK2 MAP Kinase, Protein Kinase C and Akt Kinase by Lymphoid Malignant Cells.

Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes

Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL –positive acute lymphoblastic leukemia

A Novel Fusion, KIAA0379 (Ankyrin Repeat Domain 28) to NUP98 in an Adult MDS/AML with a t(3;5;11)(p25;q35;p15).

Prognostic Implication of FLT3 and N- RAS Gene Mutations in Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only